August 25, 2017

August 25, 2017

Collaboration Is Key in MDS Research
Cure Magazine – Aug. 24
CURE spoke with Rami S. Komrokji, M.D., clinical director of Hematologic Malignancies at Moffitt Cancer Center, about these collaborations as well as some exciting treatment advances that may be coming down the pipeline.

Jermey Gable is fighting the good fight with faith
Treasure Coast News – Aug. 24
“Compared to pancreatic cancer and liver cancer this is the best-case scenario – 70% of people who have this type of lymphoma respond very well to treatments. And Jermey with your age, you’ll do fine,” explained Dr. Celeste Bello, a hematologist/oncologist at Moffitt Cancer Center as she reviewed the PET scan and other pathology reports this past summer.

Enterprise Florida marketing chief Joe Hice leaves diminished state agency to join USF
Tampa Bay Times - Aug. 24
Prior to joining Enterprise Florida in late 2015, Hice had worked for Tampa's Moffitt Cancer Center, as well as the University of Florida, North Carolina State University, Harley-Davidson Motor Co. and Segway Inc.

Moffitt's M2Gen subsidiary has a new CEO
Tampa Bay Business Journal - Aug. 24
A 30-year veteran of the pharmaceutical and biotech industry is the new president and CEO of M2Gen, a Moffitt Cancer Center subsidiary that uses big data to find ways to treat cancer. Tim Wright started work at M2Gen on July 14, assuming financial and operational leadership of the company.

Expert Q&A: Can Baby Powder Lead To Ovarian Cancer?
WebMD – Aug. 23
WebMD asked Shelley Tworoger, PhD, an epidemiologist and senior member at Moffitt Cancer Center in Tampa to sort out what’s known about talcum powder and ovarian cancer. She has studied ovarian cancer.

M2Gen Names New Executive Chair and New President and Chief Executive Officer
Press Release Point – Aug. 23
M2Gen® announced today that it has expanded its leadership by appointing M2Gen Founder William S. Dalton, PhD, MD as the new Founder & Executive Chair and naming Timothy R. Wright as its new President and Chief Executive Officer. 

New drugs push cancer treatment forward
WTVT – Aug. 23
But eventually, the medicines available on the market stopped working. Shannon's doctor at Moffitt Cancer Center wasn't giving up. Dr. Heather Han got her enrolled in a clinical trial involving this drug along with hormone therapy.

J&J Ordered to pay $417 Million in Ovarian Cancer Case
Cure Magazine – Aug. 23
However, other studies about the risks of talcum powder say differently, such as one epidemiologic review conducted by researchers at the Moffitt Cancer Center that found, “While mechanistic, pathology, and animal studies do not support evidence for the carcinogenicity of talc on the ovarian epithelium, epidemiological studies have indicated an association with talc use and increased OC [ovarian cancer] risk.”

Prostate Cancer Foundation Announces Six 2017 Challenge Awards Funded in Partnership with the Movember Foundation
USA Life Sciences – Aug. 23
Targeting Androgen Receptor and ACK1 Signaling with Novel Epigenetic Therapeutics in Castration-Resistant Prostate Cancer ($1 Million), led by Nupam Mahajan, PhD (H. Lee Moffitt Cancer Center) and Felix Feng, MD (University of California, San Francisco). 

Dr. Shah on Excitement With Venetoclax in Patients With MCL
OncLive – Aug. 22
Bijal D. Shah, MD, medical oncology, Moffitt Cancer Center, discusses the potential with venetoclax (Venclexta) in patients with mantle cell lymphoma (MCL).

Does Baby Powder Cause Cancer? A Jury Says Yes. Scientists Aren't So Sure
NPR’s All Things Considered – Aug. 22
"We can say that it is associated with an increased risk [of cancer]," says Shelley Tworoger, a cancer epidemiologist at the Moffitt Cancer Center in Tampa, Fla. "And there are biologic mechanisms by which we think that talc could actually impact ovarian cancer. But I would stop short of saying that it necessarily causes ovarian cancer." Also seen on WGVU Public Media, WLRH, GearsofBiz.com, Death Rattle Sports and WVIK.

311 coming to the Cuban Club in Tampa
Tampa Bay Times – Aug. 21
The normally amphitheater-headlining band has booked a show for Nov. 4 at the Cuban Club in Ybor City -- just a block or so from the Attic and Rock Brothers Brewing, which produces the band's signature 311 Amber Ale. Rock Brothers, which is producing this show under the moniker "Moffitt Rocks Tampa Bay"; as the band's website notes, it'll be a fundraiser for the Moffitt Cancer Center.

YOUR HEALTH: Can some breast implants cause cancer?
WQAD – Aug. 21
"The symptoms often come on years after the breast implants are surgically placed," explained Dr. Frederick Locke, an oncologist from Tampa-based Moffitt Cancer Center.

Moffitt Welcomes New Vice President of Foundation
Press Release Point – Aug. 21
Moffitt Cancer Center is proud to announce Elizabeth S. Dunn, Ph.D., as the new vice president of the Foundation. 

Fisher Phillips Attorney to Discuss Medical Marijuana’s Impact on Businesses
Florida Business Observer – Aug. 21
McGlynn will join Florida Sen. Bill Galvano and Moffitt Cancer Center’s Dr. Nagi Kumar to discuss the many ways medical marijuana affects the workplace.

With a tailored approach to cancer treatment, doctors at Moffitt see more cures, fewer side effects
Tampa Bay Times – Aug. 19
Before now, "most of the effort has been focused on drug therapy and not on radiation," said Dr. Louis Harrison, chairman of the department of radiation and oncology at Moffitt and deputy physician-in-chief. "This is a brand new area that is deserving of a lot of attention. Moffitt is a pioneer here."

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.